NewcelX NCEL
NASDAQ NCEL
$2.97 +0.05 (+1.71%)
As of: Sep 29, 2026 · 3:59 PM EDT

NewcelX (NCEL) Receivables - Net (2019 - 2025)

Updated

NewcelX (NCEL) reported Receivables - Net of $56,000 for Q2 2025, down 88.6% from $493,000 a year earlier.

Analysis

NewcelX (NCEL) Receivables - Net (2019 - 2025) Analysis & Trends

At the end of FY2024, NewcelX posted Receivables - Net of $130,000, down 71.2% from FY2023.

  • Receivables - Net has a five-year compound annual growth rate of 19.0% (FY2019 to FY2024).
  • By year, Receivables - Net came in at $451,000 in FY2023 (+54.5%), $292,000 in FY2022 and $67,954 in FY2020 (+24.8%).
  • The Q2 2025 figure ranks as the lowest quarterly Receivables - Net since Q4 2019.
  • Year over year, Receivables - Net gained in two of the last four quarters, with an average decline of 20.5%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 NewcelX 11.22 Mn 11.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 56,000.00
Dec 31, 2024 130,000.00
Jun 30, 2024 493,000.00
Dec 31, 2023 451,000.00
Jun 30, 2023 399,000.00
Dec 31, 2022 292,000.00
Dec 31, 2020 67,954.00
Dec 31, 2019 54,472.00
API Access

NewcelX Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=NCEL&period=max&api_key=YOUR_API_KEY